ArticleBiomedicines2022

Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting.

Hsin-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.